NAGOYA JOURNAL OF MEDICAL SCIENCE 84(4) 857-864 2022年11月
Patients with nonalcoholic fatty liver disease (NAFLD) have illness uncertainty. The purpose of this longitudinal study was to investigate the effect of the degree of illness uncertainty in patients with NAFLD on liver function values. We conducte...
Hideki Iwamoto   Takashi Niizeki   Hiroaki Nagamatsu   Kazuomi Ueshima   Joji Tani   Teiji Kuzuya   Kazuhiro Kasai   Youhei Kooka   Atsushi Hiraoka   Rie Sugimoto   Takehiro Yonezawa   Satoshi Tanaka   Akihiro Deguchi   Shigeo Shimose   Tomotake Shirono   Miwa Sakai   Hiroyuki Suzuki   Etsuko Moriyama   Hironori Koga   Takuji Torimura   Takumi Kawaguchi   New Fp Study Group   Kurume Liver Cancer Study Group Of Japan   
Cancers 14(19) 2022年10月
BACKGROUND: Systemic treatments are recommended for advanced hepatocellular carcinoma (HCC) in preserved liver function. However, their effects are unsatisfactory in some tumor conditions, particularly macrovascular invasion (MVI) including major ...
Introduction: Several clinical trials comparing the efficacy and safety of transarterial chemoembolization (TACE) plus molecular-targeted agents versus TACE alone revealed no clinical benefits in progression-free survival (PFS) or overall survival...
Journal of clinical medicine 11(9) 2604-2604 2022年5月
Small intestinal tumors (adenoma and adenocarcinoma, SIT) are rare, and their microRNA (miRNA) expression profiles have not been established. Previously, we reported a relationship between miRNA expression profiles and the development, growth, mor...
Anticancer research 42(4) 1905-1910 2022年4月 [査読有り]
AIM: The present study evaluated the efficacy and safety of ramucirumab (RAM) in clinical practice as post-treatment, following atezolizumab plus bevacizumab (Atz/Bev) for advanced hepatocellular carcinoma (HCC) with alpha-fetoprotein (AFP) levels...